COMPANY

Vincere Biosciences

Keywords: neurology renal kidney disease

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.3M (SBIR Phase II 1R44DK143820-01A1, new, notice Aug 28, 2026). NIH RePORTER 1R44DK143820-01A1 (Aug 28, 2026)
Evidence (1 event)
- Aug 28, 2026 · NIH RePORTER 1R44DK143820-01A1
  Organization: VINCERE BIOSCIENCES, INC.; City/State: Cambridge, MA; Project number: 1R44DK143820-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-28; FY total cost (award amount): 1297479; Administering IC: National Institute of Diabetes and Digestive and Kidney Diseases; Project title: IND-enabling studies of a USP30 inhibitor for acute kidney injury; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Aug 28, 2026 Grant Government grant — SBIR: $1.3M (annual award, as published), announced Aug 28, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗

Last 2 years.

Aug 28, 2026 Government grant — SBIR: $1.3M (annual award, as published), announced Aug 28, 2026. Agency: NIH/NIDDK. Source: government award database. source ↗